OBJECTIVES: Pediatric bipolar disorder is characterized by core deficits in mood and executive function and commonly co-occurs with attention-deficit/hyperactivity disorder (ADHD). We aimed to examine response inhibition in this population, as an element of executive function, which, if aberrant, may interfere with learning and information processing. METHODS: Children (9-18 years) with bipolar I or II disorder (BD, n = 26) and age, gender, and intelligence quotient (IQ) comparable healthy children (HC, n = 22) without any psychopathology were given a standardized Go/NoGo computerized task measuring response inhibition. A whole-brain functional magnetic resonance imaging (MRI) group analysis was performed using statistical parametric mapping software (SPM2) for comparing NoGo to Go epochs. RESULTS: There were no statistically significant group differences between groups in age, gender, or ethnicity. The BD group had high rates of co-morbid disorders, including 81% with ADHD, 62% with oppositional defiant disorder (ODD), and 46% with anxiety disorders. This BD group had fewer correct responses on Go (84% vs. 96%, T[46] = 3.35, p = 0.002) and overall (85% vs. 94%, T[46] = 4.12, p = 0.0002) trials as compared to the HC group. However, there were no statistically significant group differences in response inhibition on NoGo trials (p = 0.11). In the NoGo-Go contrast, the BD group showed increased neural activation in the right dorsolateral prefrontal cortex (DLPFC) compared to HC (T[46] = 4.21, p < 0.001). CONCLUSIONS: During accurate NoGo but impaired Go trial performance, children with BD showed increased right DLPFC activation versus controls, suggesting increased recruitment of executive control regions for accurate response inhibition. Studies relating these results to mood regulation in pediatric BD are warranted.
OBJECTIVES:Pediatric bipolar disorder is characterized by core deficits in mood and executive function and commonly co-occurs with attention-deficit/hyperactivity disorder (ADHD). We aimed to examine response inhibition in this population, as an element of executive function, which, if aberrant, may interfere with learning and information processing. METHODS:Children (9-18 years) with bipolar I or II disorder (BD, n = 26) and age, gender, and intelligence quotient (IQ) comparable healthy children (HC, n = 22) without any psychopathology were given a standardized Go/NoGo computerized task measuring response inhibition. A whole-brain functional magnetic resonance imaging (MRI) group analysis was performed using statistical parametric mapping software (SPM2) for comparing NoGo to Go epochs. RESULTS: There were no statistically significant group differences between groups in age, gender, or ethnicity. The BD group had high rates of co-morbid disorders, including 81% with ADHD, 62% with oppositional defiant disorder (ODD), and 46% with anxiety disorders. This BD group had fewer correct responses on Go (84% vs. 96%, T[46] = 3.35, p = 0.002) and overall (85% vs. 94%, T[46] = 4.12, p = 0.0002) trials as compared to the HC group. However, there were no statistically significant group differences in response inhibition on NoGo trials (p = 0.11). In the NoGo-Go contrast, the BD group showed increased neural activation in the right dorsolateral prefrontal cortex (DLPFC) compared to HC (T[46] = 4.21, p < 0.001). CONCLUSIONS: During accurate NoGo but impaired Go trial performance, children with BD showed increased right DLPFC activation versus controls, suggesting increased recruitment of executive control regions for accurate response inhibition. Studies relating these results to mood regulation in pediatric BD are warranted.
Authors: Ellen Leibenluft; Brendan A Rich; Deborah T Vinton; Eric E Nelson; Stephen J Fromm; Lisa H Berghorst; Paramjit Joshi; Adelaide Robb; Russell J Schachar; Daniel P Dickstein; Erin B McClure; Daniel S Pine Journal: Am J Psychiatry Date: 2007-01 Impact factor: 18.112
Authors: Melissa P DelBello; Dennis Hanseman; Caleb M Adler; David E Fleck; Stephen M Strakowski Journal: Am J Psychiatry Date: 2007-04 Impact factor: 18.112
Authors: Jeffery N Epstein; B J Casey; Simon T Tonev; Matthew Davidson; Allan L Reiss; Amy Garrett; Stephen P Hinshaw; Laurence L Greenhill; Alan Vitolo; Lisa A Kotler; Matthew A Jarrett; Julie Spicer Journal: Psychiatry Res Date: 2007-03-28 Impact factor: 3.222
Authors: Gin S Malhi; Jim Lagopoulos; Adrian M Owen; Belinda Ivanovski; Ron Shnier; Perminder Sachdev Journal: J Affect Disord Date: 2006-07-11 Impact factor: 4.839
Authors: Pilyoung Kim; Sarah E Jenkins; Megan E Connolly; Christen M Deveney; Stephen J Fromm; Melissa A Brotman; Eric E Nelson; Daniel S Pine; Ellen Leibenluft Journal: J Psychiatr Res Date: 2011-10-22 Impact factor: 4.791
Authors: Mani N Pavuluri; James A Ellis; Ezra Wegbreit; Alessandra M Passarotti; Michael C Stevens Journal: Behav Brain Res Date: 2011-10-08 Impact factor: 3.332
Authors: Christen M Deveney; Megan E Connolly; Sarah E Jenkins; Pilyoung Kim; Stephen J Fromm; Daniel S Pine; Ellen Leibenluft Journal: Biol Psychol Date: 2011-10-18 Impact factor: 3.251
Authors: Ryan P Cabeen; David H Laidlaw; Amanda Ruggieri; Daniel P Dickstein Journal: Psychiatry Res Neuroimaging Date: 2018-01-10 Impact factor: 2.376
Authors: Ezra Wegbreit; James A Ellis; Aneesh Nandam; Jacklynn M Fitzgerald; Alessandra M Passarotti; Mani N Pavuluri; Michael C Stevens Journal: Brain Connect Date: 2011-12-07
Authors: Isabelle E Bauer; Thomas W Frazier; Thomas D Meyer; Eric Youngstrom; Giovana B Zunta-Soares; Jair C Soares Journal: J Child Adolesc Psychopharmacol Date: 2015-10-15 Impact factor: 2.576